Second autologous stem cell transplantation for relapsed/refractory Hodgkin lymphoma after a previous autograft: a study of the lymphoma working party of the EBMT-Reference-Cited by-同舟云学术

Second autologous stem cell transplantation for relapsed/refractory Hodgkin lymphoma after a previous autograft: a study of the lymphoma working party of the EBMT

Published:2020-07-11 Issue:12 Volume:61 Page:2915-2922
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Martínez Carmen¹,Boumendil Ariane²,Romejko-Jarosinska Joanna³,Anagnostopoulos Achilles⁴,Faber Edgar⁵,Poiré Xavier⁶,Yakoub-Agha Ibrahim⁷,Akhtar Saad⁸,Gurman Gunhan⁹,Pavone Vincenzo¹⁰,Halaburda Kazimierz¹¹,Sousa Aida Botelho¹²,Ghesquières Hervé¹³,Finel Hervé²,Khvedelidze Irma²,Montoto Silvia¹⁴,Sureda Anna¹⁵

Affiliation:

1. Department of Hematology, Institute of Hematology and Oncology, Hospital Clínic, Barcelona, Spain

2. EBMT LWP Paris Office Hopital Saint-Antoine, Paris, France

3. Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland

4. George Papanicolaou General Hospital, Thessaloniki, Greece

5. University Hospital, Olomouc, Czech Republic

6. Cliniques Universitaires St. Luc, Brussels, Belgium

7. Hôpital Huriez, Lille, France

8. King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

9. Faculty of Medicine, Ankara University, Ankara, Turkey

10. Hospital C. Panico, Tricaze, Italy

11. Institute of Hematology and Transfusion Medicine, Warsaw, Poland

12. Hospital dos Capuchos, Lisboa, Portugal

13. Hospices Civils, Lyon, France

14. Department of Haemato-Oncology, St. Bartholomew’s Hospital, Barts Health NHS Trust, London, UK

15. Department of Haematology, Institut Catala d’Oncologia, Hospital Duran I Reynals, Barcelona, Spain

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1789624

Reference26 articles.

1. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

2. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

3. Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy [see comments]

4. Comparison Between Conventional Salvage Therapy and High-Dose Therapy With Autografting for Recurrent or Refractory Hodgkin's Disease

5. The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight- year study of 155 patients

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematopoietic Cell Transplantation for Hodgkin Lymphoma;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024